Closing the funding gap in harm reduction requires increased investment from both domestic governments and international donors.

At international level, we advocate for a full Global Fund replenishment and for international donor strategies, policies and processes that optimise the potential for harm reduction funding. At the national level, this involves making the case for investment through budget advocacy.